4.6 Article

Autophagy regulates biliary differentiation of hepatic progenitor cells through Notch1 signaling pathway

期刊

CELL CYCLE
卷 15, 期 12, 页码 1602-1610

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2016.1181234

关键词

autophagy; biliary differentiation; hepatic progenitor cells; Notch1

资金

  1. Key Basic Research Project of China [2012CBA01303]
  2. National Natural Science Foundation of China [81372312, 81472737, 81402018, 81402020, 81401308, 81402026, 81372330, 81572444, 81502417, 81502543]
  3. Special Funds for National Key Sci-Tech Special Project of China [2012ZX10002-016, 2012ZX10002011-011]
  4. Shanghai Science and Technology Committee [14ZD1900403, 14ZR1409200, 15PJ1410600]
  5. Shanghai Municipal Education Commission [14ZZ086]

向作者/读者索取更多资源

Autophagy plays important roles in self-renewal and differentiation of stem cells. Hepatic progenitor cells (HPCs) are thought to have the ability of self-renewal as well as possess a bipotential capacity, which allows them to differentiate into both hepatocytes and bile ductular cells. However, how autophagy contributes to self-renewal and differentiation of hepatic progenitor cells is not well understood. In this study, we use a well-established rat hepatic progenitor cell lines called WB-F344, which is treated with 3.75mM sodium butyrate (SB) to promote the differentiation of WB-F344 along the biliary phenotype. We found that autophagy was decreased in the early stage of biliary differentiation, and maintained a low level at the late stage. Activation of autophagy by rapamycin or starvation suppressed the biliary differentiation of WB-F344. Further study reported that autophagy inhibited Notch1 signaling pathway, which contributed to biliary differentiation and morphogenesis. In conclusions, autophagy regulates biliary differentiation of hepatic progenitor cells through Notch1 signaling pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment

Wen-ting Liu, Ying-ying Jing, Lu Gao, Rong Li, Xue Yang, Xiao-rong Pan, Yang Yang, Yan Meng, Xiao-juan Hou, Qiu-dong Zhao, Zhi-peng Han, Li-xin Wei

CELL DEATH AND DIFFERENTIATION (2020)

Article Biotechnology & Applied Microbiology

Sirt1-Overexpressing Mesenchymal Stem Cells Drive the Anti-tumor Effect through Their Pro-inflammatory Capacity

Fei Ye, Jinghua Jiang, Chen Zong, Xue Yang, Lu Gao, Yan Meng, Rong Li, Qiudong Zhao, Zhipeng Han, Lixin Wei

MOLECULAR THERAPY (2020)

Article Cell Biology

The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity

Shanmin Zhao, Jinghua Jiang, Yingying Jing, Wenting Liu, Xue Yang, Xiaojuan Hou, Lu Gao, Lixin Wei

CELL DEATH & DISEASE (2020)

Article Biochemistry & Molecular Biology

Ribosomal protein L34 is a potential prognostic biomarker and therapeutic target in hilar cholangiocarcinoma

Jianxin Qian, Lin Xu, Wenlong Yu, Xiaoqiang Gu, Yongjun Zuo, Ying Chen, Feng Xie, Lixin Wei

CELL AND BIOSCIENCE (2020)

Article Oncology

A TNFR2-hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells

Yan Meng, Qiudong Zhao, Liwei An, Shi Jiao, Rong Li, Yan Sang, Jianping Liao, Pingping Nie, Fuping Wen, Junyi Ju, Zhaocai Zhou, Lixin Wei

Summary: This study elucidates the importance of the TNFR2-hnRNPK-YAP signaling axis in hepatic progenitor cells during the development of primary liver cancer, as well as their upregulated expressions in PLC tissues and their association with poor prognosis.

CANCER RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Autophagy Is Required for Hepatic Differentiation of Hepatic Progenitor Cells via Wnt Signaling Pathway

Jianxing Zeng, Yingying Jing, Qionglan Wu, Jinhua Zeng, Lixin Wei, Jingfeng Liu

Summary: The study demonstrates that autophagy regulates hepatic differentiation of hepatic progenitor cells through the Wnt signaling pathway.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Cell Biology

Autophagy deficiency downregulates O6methylguanine-DNA methyltransferase and increases chemosensitivity of liver cancer cells

Xiaojuan Hou, Changchun Shao, Kai Sun, Rong Li, Lu Gao, Yan Meng, Yingying Jing, Lixin Wei

Summary: Autophagy deficiency in liver cancer cells leads to increased DNA damage, partly due to downregulation of the DNA repair enzyme MGMT. Overexpression of MGMT can reverse the chemosensitivity of liver cancer cells under autophagy deficiency.

AGING-US (2021)

Article Cell & Tissue Engineering

The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation

Changchun Shao, Xue Yang, Yingying Jing, Xiaojuan Hou, Yihua Huang, Chen Zong, Lu Gao, Wenting Liu, Jinghua Jiang, Fei Ye, Junxia Shi, Qiudong Zhao, Rong Li, Xiaoren Zhang, Lixin Wei

Summary: The study reveals a correlation between LPS/TLR4/YAP1 signaling and cell stemness, indicating that LPS plays a role in maintaining the stemness of hepatocytes in the PV area. LPS can facilitate the dedifferentiation of mature hepatocytes into progenitor-like cells for potential liver injury repair.

STEM CELL RESEARCH & THERAPY (2021)

Article Oncology

Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α

Xue Yang, Changchun Shao, Lixia Duan, Xiaojuan Hou, Yihua Huang, Lu Gao, Chen Zong, Wenting Liu, Jinghua Jiang, Fei Ye, Junxia Shi, Qiudong Zhao, Dong Wu, Lixin Wei

Summary: The study found that Oncostatin M (OSM) plays an important role in hepatocarcinogenesis by regulating liver inflammation, potentially serving as a target for the prevention and treatment of HCC, as well as an indicator for HCC prognosis.

CANCER LETTERS (2021)

Article Biotechnology & Applied Microbiology

Extracellular microparticles derived from hepatic progenitor cells deliver a death signal to hepatoma-initiating cells

Xiaojuan Hou, Wenting Liu, Xue Yang, Changchun Shao, Lu Gao, Li Zhang, Lixin Wei

Summary: This study found that extracellular microparticles derived from apoptotic hepatic progenitor cells can efficiently kill hepatoma-initiating cells and prevent hepatocarcinogenesis.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Article Cell Biology

Single cell transcriptional diversity and intercellular crosstalk of human liver cancer

Yan Meng, Yan Sang, Jianping Liao, Qiudong Zhao, Shuping Qu, Rong Li, Jinghua Jiang, Meifeng Wang, Jiahong Wang, Dong Wu, Chun Cheng, Lixin Wei

Summary: Liver cancer patients exhibit transcriptional diversity in tumor cells, which is associated with stemness and potentially driven by tumor-associated fibroblasts (TAF). Specifically, TAF interacts with heterogeneous tumor cells via COL1A1-ITGA2, and COL1A1-mediated YAP activation is mechanistically linked to increased transcriptional diversity. The levels of COL1A1, ITGA2, and YAP are also correlated with morphological heterogeneity and poor overall survival of liver cancer patients.

CELL DEATH & DISEASE (2022)

Article Cell Biology

LPS/Bcl3/YAP1 signaling promotes Sox9+HNF4α+ hepatocyte-mediated liver regeneration after hepatectomy

Changchun Shao, Yingying Jing, Shanmin Zhao, Xue Yang, Yiming Hu, Yan Meng, Yihua Huang, Fei Ye, Lu Gao, Wenting Liu, Dandan Sheng, Rong Li, Xiaoren Zhang, Lixin Wei

Summary: Sox9(+)HNF4 alpha(+) hepatocytes are generated by transition from mature hepatocytes and play an important role in liver regeneration, while Bcl3 activation promotes hepatocyte conversion and liver regeneration.

CELL DEATH & DISEASE (2022)

Article Oncology

Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study

Shuping Qu, Xiaobing Zhang, Yutian Wu, Yan Meng, Hongyu Pan, Qiang Fang, Lei Hu, Jin Zhang, Ruoyu Wang, Lixin Wei, Dong Wu

Summary: This study compared the efficacy and safety of a combination therapy of transcatheter arterial chemoembolization (TACE), Lenvatinib, and programmed cell death protein-1 (PD-1) inhibitors with TACE alone in patients with unresectable hepatocellular carcinoma (uHCC). The combination therapy showed higher tumor response rate, longer progression-free survival, and overall survival compared to TACE alone. The neutrophil-to-lymphocyte ratio was identified as an independent factor affecting survival.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+exosomes activity

Yanping Wei, Xuewu Tang, Yibin Ren, Yun Yang, Fengliang Song, Jingbo Fu, Shuowu Liu, Miao Yu, Jing Chen, Suyang Wang, Kecheng Zhang, Yexiong Tan, Zhipeng Han, Lixin Wei, Baohua Zhang, Zhangjun Cheng, Liang Li, Hongyang Wang

Summary: The study identified potential HMGB1-driven RNA-RNA crosstalk networks in HCC and explored their roles at different stages of the disease, suggesting the potential for RNA-based precision therapy. Interventions against HMGB1 and RICTOR in HCC cells demonstrated the potential to enhance the effectiveness of immunotherapy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Biochemistry & Molecular Biology

Mesenchymal stem cell therapy for liver disease: full of chances and challenges

Xue Yang, Yan Meng, Zhipeng Han, Fei Ye, Lixin Wei, Chen Zong

CELL AND BIOSCIENCE (2020)

暂无数据